Skip to main content
Jessica Altman, MD, Oncology, Chicago, IL

JessicaKaplanAltmanMD

Oncology Chicago, IL

Hematologic Oncology

Professor in Medicine-Hematology/Oncology, Northwestern University Medical School

Dr. Altman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Altman's full profile

Already have an account?

  • Office

    676 N Saint Clair St
    Ste 850
    Chicago, IL 60611
    Phone+1 312-695-4125
    Fax+1 312-695-7814

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2004 - 2007
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 2001 - 2004
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 2001

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2001 - 2026
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML  
    Daniel A Pollyea, Amir T Fathi, Geoffrey L Uy, Robert K Stuart, Mikkael A Sekeres, Courtney D DiNardo, Alice S Mims, Eyal C Attar, Richard M Stone, Hagop M Kantarjian,..., The New England Journal of Medicine

Lectures

  • Targeting Treatment According to Molecular Assessment of Acute Myeloid Leukemia 
    ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
  • MDS + AML MATTER: A Multidisciplinary Approach to Testing and Diagnosis, Evaluation of Risk, and Personalized Treatment Selection 
    60th American Society of Hematology Annual Meeting - 12/1/2018
  • Impact of Minimal Residual Disease and Achievement of Complete Remission/Complete Remission with Partial Hematologic Recovery (CR/CRh) on Overall Survival Following Tr... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Improving Treatment for Hairy Cell Leukemia
    Improving Treatment for Hairy Cell LeukemiaJanuary 11th, 2023
  • Study Shows Structural Racism Can Result in Poorer Leukemia Outcomes
    Study Shows Structural Racism Can Result in Poorer Leukemia OutcomesMarch 7th, 2022
  • Expect More Health Plans, Insurers, and Stable Premiums in 2022 as Part of Affordable Care Act
    Expect More Health Plans, Insurers, and Stable Premiums in 2022 as Part of Affordable Care ActAugust 10th, 2021
  • Join now to see all

Professional Memberships